Fosmanogepix Therapy of Disseminated Fusarium Infection
Clinical Infectious Diseases · 18.09.2023 · 77 (6) · 848-850
DOI: 10.1093/cid/ciad309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 23.05.2023. Verfasst von Drew J Winston und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, Department of Medicine, Center for Health Sciences, University of California, Los Angeles, USA. Hauptthemen laut MEDLINE: Fusariosis, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Invasive Fusarium infections cause high mortality. Fosmanogepix, a first-in-class antifungal agent, has potent activity against Fusarium. A patient with acute leukemia with invasive fusariosis, probably involving the central nervous system and caused by Fusarium lactis resistant to currently available antifungal agents, was cured of her infection with fosmanogepix. Fosmanogepix was well tolerated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology-Oncology, Department of Medicine, Center for Health Sciences, University of California, Los Angeles, USA.
- HTS Pharma Consulting, San Diego, California, USA.
Zitieren
APA
Winston, D. J., Young, P. A., Schlamm, H. T., & Schiller, G. J. (2023). Fosmanogepix Therapy of Disseminated Fusarium Infection. Clinical Infectious Diseases, 77(6), 848-850. https://doi.org/10.1093/cid/ciad309
Vancouver
Winston DJ, Young PA, Schlamm HT, Schiller GJ. Fosmanogepix Therapy of Disseminated Fusarium Infection. Clinical Infectious Diseases. 2023;77(6):848-850. doi:10.1093/cid/ciad309
BibTeX
@article{Winston2023,
author = {Winston, Drew J and Young, Patricia A and Schlamm, Haran T and Schiller, Gary J},
title = {Fosmanogepix Therapy of Disseminated Fusarium Infection},
journal = {Clinical Infectious Diseases},
year = {2023},
volume = {77},
number = {6},
pages = {848--850},
doi = {10.1093/cid/ciad309}
}
EUVIMED